Discovery of Allosteric Inhibitor against PERK as a Therapeutic Strategy for Type 2 Diabetes

Grant

Date/time Interval

  • January 1, 2019 - December 31, 2021
  • Total Award Amount

  • 65581.00
  • Direct Costs

  • 65581.00
  • Sponsor Award Id

  • 1-19-PDF-164
  • Contributor

  • Bingdong Sha Ph.D.   Principal Investigator